Soviero Asset Management, LP
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1755622
NEW YORK, NY
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$734,000
+$734,000 QoQ
Shares Held
200,000
Ownership
0.037%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#88
of 340 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in RXRX
reported options exposure · as of Dec 31, 2024CallValue
$1,554,800
CallShares
230,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Soviero Asset Management, LP holds $734,000 across 1 Biotechnology name. RXRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
200,000 | $734,000 |
All Filings in RXRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $734,000 | 200,000 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $1,554,800 | 230,000 | Call | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||